River Global Investors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.92M | Sell |
72,436
-43,338
| -37% | -$1.18M | 0.37% | 43 |
|
|
2024
Q3 | $3.35M | Buy |
115,774
+8,211
| +8% | +$240K | 0.72% | 31 |
|
|
2024
Q2 | $3.01M | Sell |
107,563
-3,894
| -3% | -$107K | 0.83% | 30 |
|
|
2024
Q1 | $3.09M | Sell |
111,457
-29,803
| -21% | -$827K | 0.78% | 29 |
|
|
2023
Q4 | $4.07M | Sell |
141,260
-576
| -0.4% | -$17.4K | 0.77% | 34 |
|
|
2023
Q3 | $4.71M | Buy |
141,836
+3,191
| +2% | +$113K | 1.1% | 16 |
|
|
2023
Q2 | $5.08M | Sell |
138,645
-7,500
| -5% | -$292K | 1.01% | 21 |
|
|
2023
Q1 | $5.96M | Sell |
146,145
-3,980
| -3% | -$172K | 1.22% | 18 |
|
|
2022
Q4 | $7.7M | Sell |
150,125
-46,921
| -24% | -$2.25M | 1.65% | 12 |
|
|
2022
Q3 | $8.64M | Buy |
197,046
+28,620
| +17% | +$1.39M | 1.66% | 12 |
|
|
2022
Q2 | $8.84M | Sell |
168,426
-6,523
| -4% | -$332K | 1.57% | 14 |
|
|
2022
Q1 | $9.06M | Sell |
174,949
-14,560
| -8% | -$755K | 1.19% | 22 |
|
|
2021
Q4 | $11.2M | Sell |
189,509
-58,000
| -23% | -$2.87M | 0.87% | 20 |
|
|
2021
Q3 | $10.6M | Sell |
247,509
-145,636
| -37% | -$6.45M | 0.83% | 18 |
|
|
2021
Q2 | $15.4M | Sell |
393,145
-6,334
| -2% | -$246K | 1% | 17 |
|
|
2021
Q1 | $14.5M | Buy |
399,479
+39,438
| +11% | +$1.4M | 0.87% | 25 |
|
|
2020
Q4 | $13.2M | Sell |
360,041
-11,170
| -3% | -$410K | 0.76% | 18 |
|
|
2020
Q3 | $12.9M | Sell |
371,211
-13,976
| -4% | -$490K | 0.96% | 17 |
|
|
2020
Q2 | $11.9M | Sell |
385,187
-37,417
| -9% | -$1.27M | 0.87% | 18 |
|
|
2020
Q1 | $13.1M | Sell |
422,604
-20,564
| -5% | -$701K | 1.2% | 12 |
|
|
2019
Q4 | $16.5M | Buy |
443,168
+20,775
| +5% | +$740K | 0.91% | 24 |
|
|
2019
Q3 | $14.4M | Buy |
422,393
+138,391
| +49% | +$5.03M | 1.01% | 20 |
|
|
2019
Q2 | $11.7M | Buy |
284,002
+1,054
| +0.4% | +$41.9K | 0.82% | 30 |
|
|
2019
Q1 | $11.4M | Hold |
282,948
| – | – | 0.8% | 28 |
|
|
2018
Q4 | $11.7M | Buy |
282,948
+175,859
| +164% | +$7.3M | 1.02% | 17 |
|
|
2018
Q3 | $4.48M | Buy |
107,089
+45,006
| +72% | +$1.73M | 0.41% | 75 |
|
|
2018
Q2 | $2.14M | Sell |
62,083
-84,718
| -58% | -$2.9M | 0.22% | 108 |
|
|
2018
Q1 | $4.95M | Sell |
146,801
-2,635
| -2% | -$90.6K | 0.58% | 55 |
|
|
2017
Q4 | $5.14M | Buy |
149,436
+75,867
| +103% | +$2.59M | 0.58% | 55 |
|
|
2017
Q3 | $2.49M | Sell |
73,569
-83,162
| -53% | -$2.67M | 0.37% | 85 |
|
|
2017
Q2 | $5M | Sell |
156,731
-70,723
| -31% | -$2.23M | 0.93% | 32 |
|
|
2017
Q1 | $7.38M | Sell |
227,454
-16,442
| -7% | -$518K | 1.65% | 11 |
|
|
2016
Q4 | $7.52M | Buy |
243,896
+20,026
| +9% | +$611K | 2.13% | 7 |
|
|
2016
Q3 | $7.19M | Buy |
223,870
+14,434
| +7% | +$483K | 2.29% | 5 |
|
|
2016
Q2 | $7M | Buy |
209,436
+94,333
| +82% | +$3.01M | 3.02% | 3 |
|
|
2016
Q1 | $3.23M | Buy |
115,103
+2,002
| +2% | +$57.2K | 2.08% | 8 |
|
|
2015
Q4 | $3.46M | Buy |
+113,101
| New | +$3.56M | 2.36% | 7 |
|
|
2015
Q2 | $506K | Sell |
15,922
-378,716
| -96% | -$12.3M | 0.64% | 40 |
|
|
2015
Q1 | $13M | Sell |
394,638
-231,778
| -37% | -$7.37M | 4.93% | 6 |
|
|
2014
Q4 | $18.5M | Sell |
626,416
-92,726
| -13% | -$2.66M | 4.56% | 9 |
|
|
2014
Q3 | $20.2M | Sell |
719,142
-16,377
| -2% | -$460K | 3.97% | 6 |
|
|
2014
Q2 | $20.7M | Buy |
+735,519
| New | +$21M | 5.39% | 7 |
|
|
2013
Q4 | – | Sell |
-11,293
| Closed | -$307K | – | 77 |
|
|
2013
Q3 | $307K | Sell |
11,293
-1,040,194
| -99% | -$28.3M | 0.07% | 76 |
|
|
2013
Q2 | $28M | Buy |
+1,051,487
| New | +$29.1M | 4.53% | 5 |
|
Other funds holding PFE
River Global Investors's PFE Position: Q4 2024 in Review
River Global Investors reduced its Pfizer (PFE) stake by 37% in Q4 2024, selling an estimated $1.18M and leaving 72,436 shares worth $1.92M. The position accounts for 0.37% of the portfolio, ranked #43.
River Global Investors first reported a position in PFE in Q2 2013 and has held it in 44 quarters since. The position peaked at $28M in Q2 2013. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- River Global Investors held 72,436 shares of Pfizer worth $1.92M as of Q4 2024.
- River Global Investors sold 43,338 Pfizer shares in Q4 2024, an estimated $1.18M.
- Pfizer made up 0.37% of River Global Investors's portfolio in Q4 2024, its #43 holding.
- River Global Investors first reported a position in Pfizer in Q2 2013 and has held it in 44 quarters since.
- River Global Investors's Pfizer position peaked at $28M in Q2 2013.
- 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on River Global Investors's 13F filing for Q4 2024, filed 7 Feb 2025.